AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹7.94 Cr | ₹14 Cr | ₹7.19 Cr | ₹6.86 Cr | - |
What is the latest Contingent Liabilities ratio of AARTI PHARMALABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹7.94 Cr |
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹7.19 Cr |
| Mar2023 | ₹6.86 Cr |
| Mar2022 | - |
How is Contingent Liabilities of AARTI PHARMALABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.94 Cr | -42.95 | |
| Mar2025 | ₹14 Cr | 93.53 | |
| Mar2024 | ₹7.19 Cr | 4.78 | |
| Mar2023 | ₹6.86 Cr | 0 | |
| Mar2022 | - | - | |
Compare Contingent Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,763.0 Cr | -9.6% | -1.4% | 6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -9.6% |
-1.4% |
6.2% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses